Global Peripheral Parenteral Nutrition (PPN) Market Research Report 2023

Report ID: 1808033 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Carbohydrates
        1.2.3 Parenteral Lipid Emulsion
        1.2.4 Single Dose Amino Acid Solution
        1.2.5 Trace Elements
        1.2.6 Vitamins and Minerals
    1.3 Market by Application
        1.3.1 Global Peripheral Parenteral Nutrition (PPN) Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Home
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Peripheral Parenteral Nutrition (PPN) Market Perspective (2017-2028)
    2.2 Peripheral Parenteral Nutrition (PPN) Growth Trends by Region
        2.2.1 Peripheral Parenteral Nutrition (PPN) Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Peripheral Parenteral Nutrition (PPN) Historic Market Size by Region (2017-2022)
        2.2.3 Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Region (2023-2028)
    2.3 Peripheral Parenteral Nutrition (PPN) Market Dynamics
        2.3.1 Peripheral Parenteral Nutrition (PPN) Industry Trends
        2.3.2 Peripheral Parenteral Nutrition (PPN) Market Drivers
        2.3.3 Peripheral Parenteral Nutrition (PPN) Market Challenges
        2.3.4 Peripheral Parenteral Nutrition (PPN) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Peripheral Parenteral Nutrition (PPN) Players by Revenue
        3.1.1 Global Top Peripheral Parenteral Nutrition (PPN) Players by Revenue (2017-2022)
        3.1.2 Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Players (2017-2022)
    3.2 Global Peripheral Parenteral Nutrition (PPN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Peripheral Parenteral Nutrition (PPN) Revenue
    3.4 Global Peripheral Parenteral Nutrition (PPN) Market Concentration Ratio
        3.4.1 Global Peripheral Parenteral Nutrition (PPN) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Peripheral Parenteral Nutrition (PPN) Revenue in 2021
    3.5 Peripheral Parenteral Nutrition (PPN) Key Players Head office and Area Served
    3.6 Key Players Peripheral Parenteral Nutrition (PPN) Product Solution and Service
    3.7 Date of Enter into Peripheral Parenteral Nutrition (PPN) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Parenteral Nutrition (PPN) Breakdown Data by Type
    4.1 Global Peripheral Parenteral Nutrition (PPN) Historic Market Size by Type (2017-2022)
    4.2 Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Type (2023-2028)
5 Peripheral Parenteral Nutrition (PPN) Breakdown Data by Application
    5.1 Global Peripheral Parenteral Nutrition (PPN) Historic Market Size by Application (2017-2022)
    5.2 Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Peripheral Parenteral Nutrition (PPN) Market Size (2017-2028)
    6.2 North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2017-2022)
    6.3 North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Peripheral Parenteral Nutrition (PPN) Market Size (2017-2028)
    7.2 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2017-2022)
    7.3 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size (2017-2028)
    8.2 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Country (2017-2022)
    8.3 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Peripheral Parenteral Nutrition (PPN) Market Size (2017-2028)
    9.2 Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2017-2022)
    9.3 Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size (2017-2028)
    10.2 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2017-2022)
    10.3 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Eurofarma
        11.1.1 Eurofarma Company Detail
        11.1.2 Eurofarma Business Overview
        11.1.3 Eurofarma Peripheral Parenteral Nutrition (PPN) Introduction
        11.1.4 Eurofarma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
        11.1.5 Eurofarma Recent Development
    11.2 Corporacion De Laboratorios Farmaceuticos
        11.2.1 Corporacion De Laboratorios Farmaceuticos Company Detail
        11.2.2 Corporacion De Laboratorios Farmaceuticos Business Overview
        11.2.3 Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Introduction
        11.2.4 Corporacion De Laboratorios Farmaceuticos Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
        11.2.5 Corporacion De Laboratorios Farmaceuticos Recent Development
    11.3 Baxter International Inc.
        11.3.1 Baxter International Inc. Company Detail
        11.3.2 Baxter International Inc. Business Overview
        11.3.3 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Introduction
        11.3.4 Baxter International Inc. Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
        11.3.5 Baxter International Inc. Recent Development
    11.4 Kelun Pharma
        11.4.1 Kelun Pharma Company Detail
        11.4.2 Kelun Pharma Business Overview
        11.4.3 Kelun Pharma Peripheral Parenteral Nutrition (PPN) Introduction
        11.4.4 Kelun Pharma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
        11.4.5 Kelun Pharma Recent Development
    11.5 B. Braun
        11.5.1 B. Braun Company Detail
        11.5.2 B. Braun Business Overview
        11.5.3 B. Braun Peripheral Parenteral Nutrition (PPN) Introduction
        11.5.4 B. Braun Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
        11.5.5 B. Braun Recent Development
    11.6 Fresenius
        11.6.1 Fresenius Company Detail
        11.6.2 Fresenius Business Overview
        11.6.3 Fresenius Peripheral Parenteral Nutrition (PPN) Introduction
        11.6.4 Fresenius Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
        11.6.5 Fresenius Recent Development
    11.7 Teva Pharmaceutical Industries
        11.7.1 Teva Pharmaceutical Industries Company Detail
        11.7.2 Teva Pharmaceutical Industries Business Overview
        11.7.3 Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Introduction
        11.7.4 Teva Pharmaceutical Industries Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
        11.7.5 Teva Pharmaceutical Industries Recent Development
    11.8 Pfizer (Hospira)
        11.8.1 Pfizer (Hospira) Company Detail
        11.8.2 Pfizer (Hospira) Business Overview
        11.8.3 Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Introduction
        11.8.4 Pfizer (Hospira) Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
        11.8.5 Pfizer (Hospira) Recent Development
    11.9 Ostuka Pharmaceutical
        11.9.1 Ostuka Pharmaceutical Company Detail
        11.9.2 Ostuka Pharmaceutical Business Overview
        11.9.3 Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Introduction
        11.9.4 Ostuka Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
        11.9.5 Ostuka Pharmaceutical Recent Development
    11.10 Laboratorios Biogalenic
        11.10.1 Laboratorios Biogalenic Company Detail
        11.10.2 Laboratorios Biogalenic Business Overview
        11.10.3 Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Introduction
        11.10.4 Laboratorios Biogalenic Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
        11.10.5 Laboratorios Biogalenic Recent Development
    11.11 Laboratorios Finlay
        11.11.1 Laboratorios Finlay Company Detail
        11.11.2 Laboratorios Finlay Business Overview
        11.11.3 Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Introduction
        11.11.4 Laboratorios Finlay Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
        11.11.5 Laboratorios Finlay Recent Development
    11.12 Grifols International
        11.12.1 Grifols International Company Detail
        11.12.2 Grifols International Business Overview
        11.12.3 Grifols International Peripheral Parenteral Nutrition (PPN) Introduction
        11.12.4 Grifols International Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
        11.12.5 Grifols International Recent Development
    11.13 Fresenius Kabi
        11.13.1 Fresenius Kabi Company Detail
        11.13.2 Fresenius Kabi Business Overview
        11.13.3 Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Introduction
        11.13.4 Fresenius Kabi Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
        11.13.5 Fresenius Kabi Recent Development
    11.14 Sichuan Kelun Pharmaceutical
        11.14.1 Sichuan Kelun Pharmaceutical Company Detail
        11.14.2 Sichuan Kelun Pharmaceutical Business Overview
        11.14.3 Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Introduction
        11.14.4 Sichuan Kelun Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
        11.14.5 Sichuan Kelun Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Carbohydrates
    Table 3. Key Players of Parenteral Lipid Emulsion
    Table 4. Key Players of Single Dose Amino Acid Solution
    Table 5. Key Players of Trace Elements
    Table 6. Key Players of Vitamins and Minerals
    Table 7. Global Peripheral Parenteral Nutrition (PPN) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Peripheral Parenteral Nutrition (PPN) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Peripheral Parenteral Nutrition (PPN) Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Peripheral Parenteral Nutrition (PPN) Market Share by Region (2017-2022)
    Table 11. Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Peripheral Parenteral Nutrition (PPN) Market Share by Region (2023-2028)
    Table 13. Peripheral Parenteral Nutrition (PPN) Market Trends
    Table 14. Peripheral Parenteral Nutrition (PPN) Market Drivers
    Table 15. Peripheral Parenteral Nutrition (PPN) Market Challenges
    Table 16. Peripheral Parenteral Nutrition (PPN) Market Restraints
    Table 17. Global Peripheral Parenteral Nutrition (PPN) Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Peripheral Parenteral Nutrition (PPN) Market Share by Players (2017-2022)
    Table 19. Global Top Peripheral Parenteral Nutrition (PPN) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) as of 2021)
    Table 20. Ranking of Global Top Peripheral Parenteral Nutrition (PPN) Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Peripheral Parenteral Nutrition (PPN) Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Peripheral Parenteral Nutrition (PPN) Product Solution and Service
    Table 24. Date of Enter into Peripheral Parenteral Nutrition (PPN) Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Peripheral Parenteral Nutrition (PPN) Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Type (2017-2022)
    Table 28. Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Type (2023-2028)
    Table 30. Global Peripheral Parenteral Nutrition (PPN) Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Application (2017-2022)
    Table 32. Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Application (2023-2028)
    Table 34. North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Eurofarma Company Detail
    Table 45. Eurofarma Business Overview
    Table 46. Eurofarma Peripheral Parenteral Nutrition (PPN) Product
    Table 47. Eurofarma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
    Table 48. Eurofarma Recent Development
    Table 49. Corporacion De Laboratorios Farmaceuticos Company Detail
    Table 50. Corporacion De Laboratorios Farmaceuticos Business Overview
    Table 51. Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Product
    Table 52. Corporacion De Laboratorios Farmaceuticos Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
    Table 53. Corporacion De Laboratorios Farmaceuticos Recent Development
    Table 54. Baxter International Inc. Company Detail
    Table 55. Baxter International Inc. Business Overview
    Table 56. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Product
    Table 57. Baxter International Inc. Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
    Table 58. Baxter International Inc. Recent Development
    Table 59. Kelun Pharma Company Detail
    Table 60. Kelun Pharma Business Overview
    Table 61. Kelun Pharma Peripheral Parenteral Nutrition (PPN) Product
    Table 62. Kelun Pharma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
    Table 63. Kelun Pharma Recent Development
    Table 64. B. Braun Company Detail
    Table 65. B. Braun Business Overview
    Table 66. B. Braun Peripheral Parenteral Nutrition (PPN) Product
    Table 67. B. Braun Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
    Table 68. B. Braun Recent Development
    Table 69. Fresenius Company Detail
    Table 70. Fresenius Business Overview
    Table 71. Fresenius Peripheral Parenteral Nutrition (PPN) Product
    Table 72. Fresenius Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
    Table 73. Fresenius Recent Development
    Table 74. Teva Pharmaceutical Industries Company Detail
    Table 75. Teva Pharmaceutical Industries Business Overview
    Table 76. Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Product
    Table 77. Teva Pharmaceutical Industries Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
    Table 78. Teva Pharmaceutical Industries Recent Development
    Table 79. Pfizer (Hospira) Company Detail
    Table 80. Pfizer (Hospira) Business Overview
    Table 81. Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Product
    Table 82. Pfizer (Hospira) Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
    Table 83. Pfizer (Hospira) Recent Development
    Table 84. Ostuka Pharmaceutical Company Detail
    Table 85. Ostuka Pharmaceutical Business Overview
    Table 86. Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product
    Table 87. Ostuka Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
    Table 88. Ostuka Pharmaceutical Recent Development
    Table 89. Laboratorios Biogalenic Company Detail
    Table 90. Laboratorios Biogalenic Business Overview
    Table 91. Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Product
    Table 92. Laboratorios Biogalenic Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
    Table 93. Laboratorios Biogalenic Recent Development
    Table 94. Laboratorios Finlay Company Detail
    Table 95. Laboratorios Finlay Business Overview
    Table 96. Laboratorios Finlay Peripheral Parenteral Nutrition (PPN)Product
    Table 97. Laboratorios Finlay Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
    Table 98. Laboratorios Finlay Recent Development
    Table 99. Grifols International Company Detail
    Table 100. Grifols International Business Overview
    Table 101. Grifols International Peripheral Parenteral Nutrition (PPN)Product
    Table 102. Grifols International Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
    Table 103. Grifols International Recent Development
    Table 104. Fresenius Kabi Company Detail
    Table 105. Fresenius Kabi Business Overview
    Table 106. Fresenius Kabi Peripheral Parenteral Nutrition (PPN)Product
    Table 107. Fresenius Kabi Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
    Table 108. Fresenius Kabi Recent Development
    Table 109. Sichuan Kelun Pharmaceutical Company Detail
    Table 110. Sichuan Kelun Pharmaceutical Business Overview
    Table 111. Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN)Product
    Table 112. Sichuan Kelun Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2017-2022) & (US$ Million)
    Table 113. Sichuan Kelun Pharmaceutical Recent Development
    Table 114. Research Programs/Design for This Report
    Table 115. Key Data Information from Secondary Sources
    Table 116. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Peripheral Parenteral Nutrition (PPN) Market Share by Type: 2021 VS 2028
    Figure 2. Carbohydrates Features
    Figure 3. Parenteral Lipid Emulsion Features
    Figure 4. Single Dose Amino Acid Solution Features
    Figure 5. Trace Elements Features
    Figure 6. Vitamins and Minerals Features
    Figure 7. Global Peripheral Parenteral Nutrition (PPN) Market Share by Application in 2021 & 2028
    Figure 8. Hospital Case Studies
    Figure 9. Home Case Studies
    Figure 10. Peripheral Parenteral Nutrition (PPN) Report Years Considered
    Figure 11. Global Peripheral Parenteral Nutrition (PPN) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Peripheral Parenteral Nutrition (PPN) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Peripheral Parenteral Nutrition (PPN) Market Share by Region: 2021 VS 2028
    Figure 14. Global Peripheral Parenteral Nutrition (PPN) Market Share by Players in 2021
    Figure 15. Global Top Peripheral Parenteral Nutrition (PPN) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Peripheral Parenteral Nutrition (PPN) Revenue in 2021
    Figure 17. North America Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Peripheral Parenteral Nutrition (PPN) Market Share by Country (2017-2028)
    Figure 19. United States Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Peripheral Parenteral Nutrition (PPN) Market Share by Country (2017-2028)
    Figure 23. Germany Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Share by Region (2017-2028)
    Figure 31. China Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Peripheral Parenteral Nutrition (PPN) Market Share by Country (2017-2028)
    Figure 39. Mexico Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Share by Country (2017-2028)
    Figure 43. Turkey Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Eurofarma Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
    Figure 46. Corporacion De Laboratorios Farmaceuticos Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
    Figure 47. Baxter International Inc. Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
    Figure 48. Kelun Pharma Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
    Figure 49. B. Braun Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
    Figure 50. Fresenius Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
    Figure 51. Teva Pharmaceutical Industries Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
    Figure 52. Pfizer (Hospira) Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
    Figure 53. Ostuka Pharmaceutical Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
    Figure 54. Laboratorios Biogalenic Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
    Figure 55. Laboratorios Finlay Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
    Figure 56. Grifols International Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
    Figure 57. Fresenius Kabi Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
    Figure 58. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2017-2022)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eurofarma
Corporacion De Laboratorios Farmaceuticos
Baxter International Inc.
Kelun Pharma
B. Braun
Fresenius
Teva Pharmaceutical Industries
Pfizer (Hospira)
Ostuka Pharmaceutical
Laboratorios Biogalenic
Laboratorios Finlay
Grifols International
Fresenius Kabi
Sichuan Kelun Pharmaceutical
Frequently Asked Questions
Peripheral Parenteral Nutrition (PPN) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Peripheral Parenteral Nutrition (PPN) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Peripheral Parenteral Nutrition (PPN) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Dialysis Cartridge

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More